Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

FRA:TR1 - Deutsche Boerse Ag - US74144T1088 - Common Stock - Currency: EUR

83.78  -0.1 (-0.12%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to TR1. TR1 was compared to 114 industry peers in the Capital Markets industry. TR1 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TR1 may be a bit undervalued, certainly considering the very reasonable score on growth TR1 also has an excellent dividend rating. These ratings would make TR1 suitable for value and dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

TR1 had positive earnings in the past year.
In the past year TR1 had a positive cash flow from operations.
Each year in the past 5 years TR1 has been profitable.
In the past 5 years TR1 always reported a positive cash flow from operatings.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

TR1's Return On Assets of 14.04% is amongst the best of the industry. TR1 outperforms 95.61% of its industry peers.
Looking at the Return On Equity, with a value of 18.90%, TR1 belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
With an excellent Return On Invested Capital value of 14.17%, TR1 belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TR1 is significantly above the industry average of 8.01%.
Industry RankSector Rank
ROA 14.04%
ROE 18.9%
ROIC 14.17%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

TR1 has a better Profit Margin (27.64%) than 77.19% of its industry peers.
In the last couple of years the Profit Margin of TR1 has declined.
TR1 has a Operating Margin of 33.61%. This is in the better half of the industry: TR1 outperforms 77.19% of its industry peers.
In the last couple of years the Operating Margin of TR1 has declined.
Industry RankSector Rank
OM 33.61%
PM (TTM) 27.64%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, TR1 has less shares outstanding
Compared to 5 years ago, TR1 has less shares outstanding
The debt/assets ratio for TR1 has been reduced compared to a year ago.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 5.78 indicates that TR1 is not in any danger for bankruptcy at the moment.
TR1 has a Altman-Z score of 5.78. This is amongst the best in the industry. TR1 outperforms 90.35% of its industry peers.
The Debt to FCF ratio of TR1 is 0.03, which is an excellent value as it means it would take TR1, only 0.03 years of fcf income to pay off all of its debts.
TR1 has a better Debt to FCF ratio (0.03) than 98.25% of its industry peers.
TR1 has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, TR1 belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 5.78
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 2.61 indicates that TR1 has no problem at all paying its short term obligations.
TR1 has a Current ratio of 2.61. This is amongst the best in the industry. TR1 outperforms 82.46% of its industry peers.
A Quick Ratio of 2.61 indicates that TR1 has no problem at all paying its short term obligations.
TR1's Quick ratio of 2.61 is amongst the best of the industry. TR1 outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 2.61
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.74% over the past year.
Measured over the past 5 years, TR1 shows a small growth in Earnings Per Share. The EPS has been growing by 2.42% on average per year.
TR1 shows a small growth in Revenue. In the last year, the Revenue has grown by 6.51%.
The Revenue has been growing slightly by 4.78% on average over the past years.
EPS 1Y (TTM)10.74%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-6.3%
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%0.78%

3.2 Future

The Earnings Per Share is expected to grow by 3.59% on average over the next years.
The Revenue is expected to grow by 2.79% on average over the next years.
EPS Next Y-10.03%
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%
EPS Next 5Y3.59%
Revenue Next Year-2.61%
Revenue Next 2Y0.03%
Revenue Next 3Y1.1%
Revenue Next 5Y2.79%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.33, the valuation of TR1 can be described as reasonable.
TR1's Price/Earnings ratio is rather cheap when compared to the industry. TR1 is cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Earnings ratio of TR1 to the average of the S&P500 Index (26.17), we can say TR1 is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.02, the valuation of TR1 can be described as very reasonable.
81.58% of the companies in the same industry are more expensive than TR1, based on the Price/Forward Earnings ratio.
TR1 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.33
Fwd PE 11.02
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

85.96% of the companies in the same industry are more expensive than TR1, based on the Enterprise Value to EBITDA ratio.
TR1's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TR1 is cheaper than 80.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.34
EV/EBITDA 6.83
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of TR1 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.27
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%

7

5. Dividend

5.1 Amount

TR1 has a Yearly Dividend Yield of 5.34%, which is a nice return.
TR1's Dividend Yield is rather good when compared to the industry average which is at 5.98. TR1 pays more dividend than 86.84% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, TR1 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.34%

5.2 History

On average, the dividend of TR1 grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

57.96% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.96%
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (5/28/2025, 7:00:00 PM)

83.78

-0.1 (-0.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-24 2025-07-24/amc
Inst Owners79.04%
Inst Owner ChangeN/A
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap18.46B
Analysts50
Price Target83.08 (-0.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.34%
Yearly Dividend4.5
Dividend Growth(5Y)10.37%
DP57.96%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.33%
Min EPS beat(2)-5.31%
Max EPS beat(2)2.66%
EPS beat(4)2
Avg EPS beat(4)0.76%
Min EPS beat(4)-5.31%
Max EPS beat(4)7.98%
EPS beat(8)6
Avg EPS beat(8)7.08%
EPS beat(12)9
Avg EPS beat(12)3.35%
EPS beat(16)10
Avg EPS beat(16)1.9%
Revenue beat(2)0
Avg Revenue beat(2)-3.65%
Min Revenue beat(2)-4.33%
Max Revenue beat(2)-2.98%
Revenue beat(4)0
Avg Revenue beat(4)-4.31%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)-2.98%
Revenue beat(8)2
Avg Revenue beat(8)-2.39%
Revenue beat(12)3
Avg Revenue beat(12)-2.9%
Revenue beat(16)3
Avg Revenue beat(16)-2.69%
PT rev (1m)-16.8%
PT rev (3m)-22.76%
EPS NQ rev (1m)-6.51%
EPS NQ rev (3m)-13.05%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-10.86%
Revenue NQ rev (1m)-4.62%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)-1.66%
Revenue NY rev (3m)-6.57%
Valuation
Industry RankSector Rank
PE 10.33
Fwd PE 11.02
P/S 2.94
P/FCF 16.34
P/OCF 12.43
P/B 2.01
P/tB 2.82
EV/EBITDA 6.83
EPS(TTM)8.11
EY9.68%
EPS(NY)7.6
Fwd EY9.07%
FCF(TTM)5.13
FCFY6.12%
OCF(TTM)6.74
OCFY8.05%
SpS28.5
BVpS41.69
TBVpS29.71
PEG (NY)N/A
PEG (5Y)4.27
Profitability
Industry RankSector Rank
ROA 14.04%
ROE 18.9%
ROCE 19.03%
ROIC 14.17%
ROICexc 18.29%
ROICexgc 29.81%
OM 33.61%
PM (TTM) 27.64%
GM N/A
FCFM 17.99%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexcg growth 3Y-16.2%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.02
Cap/Depr 157.94%
Cap/Sales 5.67%
Interest Coverage 250
Cash Conversion 63.6%
Profit Quality 65.07%
Current Ratio 2.61
Quick Ratio 2.61
Altman-Z 5.78
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)10.74%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-6.3%
EPS Next Y-10.03%
EPS Next 2Y-3.99%
EPS Next 3Y-1.81%
EPS Next 5Y3.59%
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%0.78%
Revenue Next Year-2.61%
Revenue Next 2Y0.03%
Revenue Next 3Y1.1%
Revenue Next 5Y2.79%
EBIT growth 1Y11.46%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year-6.5%
EBIT Next 3Y0.33%
EBIT Next 5Y4.53%
FCF growth 1Y-16.14%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y-4.89%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%